Drugs / Gemigliptin/Dapagliflozin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04544319 | Oct 2020 → Mar 2021 | type 2 diabetes mellitus | LG Chem | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gemigliptin/Dapagliflozin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04544319 ↗ |